Bionow Neuroscience Conference 2024

Discovery, Development and Commercialisation of Neuroscience

Introducing the inaugural Bionow Neuroscience conference 2024. Created to bring together academics, clinicians and industry experts in the spirit of collaboration & growth.

The Bionow Neuroscience Conference 2024 aims to highlight the strengths in the discovery, development and commercialisation of neuroscience treatments and technologies. For the event, it will showcase key developments across neuroscience. This includes a range of neurological diseases and conditions such as Alzheimer’s disease, Cerebal palsy, Dementia, Epilepsy, Huntington’s disease, Motor Neurone disease and Parkinson’s disease.

The conference will explore the current challenges and opportunities facing Neuroscience. Therefore, highlighting the new approaches that will create opportunities for R&D, commercialisation and implementation plus will consider the impact on patient outcomes.

Accelerating Diagnosis and Treatment of Neurological Diseases

However, bringing the expertise, funding and new technologies together in neuroscience is one of the biggest challenges facing the Life Sciences sector and society at large. As a result, the aim of the Bionow Neuroscience Conference 2024 is to bring together all these elements. In doing so, contributing to the eradication of these diseases.

Learn more about the conference and the opportunities in accelerating diagnosis and treatment of Neurological Diseases.